GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a significant focus in healthcare investigation, largely due to its notable impact on treating diseases such as type 2 diabetes and weight gain. New studies have demonstrated that beyond glucose control, GLP-1 drugs offer promise for heart function and perhaps cogn